Spremljaj
Courtney Hebert
Naslov
Navedeno
Navedeno
Leto
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway
WA Wilmer, CL Dixon, C Hebert
Kidney international 60 (3), 858-871, 2001
1942001
Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 US patients, 2013–14
NS Shah, JA Greenberg, MC McNulty, KS Gregg, J Riddell IV, ...
Journal of Clinical Virology 80, 12-19, 2016
1122016
Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining “post” is important in understanding and treating infection-related …
RJ Glassock, A Alvarado, J Prosek, C Hebert, S Parikh, A Satoskar, ...
American Journal of Kidney Diseases 65 (6), 826-832, 2015
892015
Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid
C Hebert, J Ridgway, B Vekhter, EC Brown, SG Weber, A Robicsek
Infection Control & Hospital Epidemiology 33 (4), 381-388, 2012
792012
Diagnosis-specific readmission risk prediction using electronic health data: a retrospective cohort study
C Hebert, C Shivade, R Foraker, J Wasserman, C Roth, H Mekhjian, ...
BMC medical informatics and decision making 14 (1), 1-9, 2014
762014
Life after endometrial cancer: A systematic review of patient-reported outcomes
R Shisler, JA Sinnott, V Wang, C Hebert, R Salani, AS Felix
Gynecologic oncology 148 (2), 403-413, 2018
752018
Severe influenza in 33 US hospitals, 2013–2014: complications and risk factors for death in 507 patients
NS Shah, JA Greenberg, MC McNulty, KS Gregg, J Riddell, JE Mangino, ...
infection control & hospital epidemiology 36 (11), 1251-1260, 2015
612015
Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection Relapse
C Hebert, H Du, LR Peterson, A Robicsek
Infection Control & Hospital Epidemiology 34 (4), 407-414, 2013
612013
Decolonization therapy in infection control
C Hebert, A Robicsek
Current opinion in infectious diseases 23 (4), 340-345, 2010
542010
Textual inference for eligibility criteria resolution in clinical trials
C Shivade, C Hebert, M Lopetegui, MC De Marneffe, E Fosler-Lussier, ...
Journal of biomedical informatics 58, S211-S218, 2015
482015
PPAR-α ligands inhibit H2O2-mediated activation of transforming growth factor-β1 in human mesangial cells
WA Wilmer, CL Dixon, C Hebert, L Lu, BH Rovin
Antioxidants and Redox Signaling 4 (6), 877-884, 2002
442002
Clinical Significance of Methicillin-Resistant Staphylococcus aureus Colonization on Hospital Admission: One-Year Infection Risk
JP Ridgway, LR Peterson, EC Brown, H Du, C Hebert, RB Thomson Jr, ...
PLOS ONE 8 (11), e79716, 2013
282013
Management practices for leaders to promote infection prevention: lessons from a qualitative study
AS McAlearney, AA Gaughan, MJ DePuccio, SR MacEwan, C Hebert, ...
American Journal of Infection Control 49 (5), 536-541, 2021
252021
Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA)
C Hebert, SG Weber
Infectious Disease Clinics 25 (1), 181-200, 2011
252011
ICARUS: minimizing human effort in iterative data completion
P Rahman, C Hebert, A Nandi
Proceedings of the VLDB Endowment. International Conference on Very Large …, 2018
242018
Development and validation of an automated ventilator-associated event electronic surveillance system: A report of a successful implementation
C Hebert, J Flaherty, J Smyer, J Ding, JE Mangino
American journal of infection control 46 (3), 316-321, 2018
242018
The Influence of Context on Antimicrobial Prescribing for Febrile Respiratory IllnessA Cohort Study
C Hebert, J Beaumont, G Schwartz, A Robicsek
Annals of internal medicine 157 (3), 160-169, 2012
242012
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains
C Hebert, R Villaran, J Tolentino, L Best, S Boonlayangoor, D Pitrak, ...
Scandinavian journal of infectious diseases 42 (6-7), 506-509, 2010
242010
Searching for management approaches to reduce HAI transmission (SMART): a study protocol
AS McAlearney, JL Hefner, CJ Sieck, DM Walker, AM Aldrich, LN Sova, ...
Implementation Science 12 (1), 1-11, 2017
182017
Prediction of antibiotic susceptibility for urinary tract infection in a hospital setting
C Hebert, Y Gao, P Rahman, C Dewart, M Lustberg, P Pancholi, ...
Antimicrobial agents and chemotherapy 64 (7), e02236-19, 2020
162020
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20